title: First-line chemotherapy for metastatic breast cancer in patients ≥75 years: a retrospective single-centre analysis.
authors.affiliation: Institut Bergonié, South-West Comprehensive Cancer Center, Bordeaux, France. debled@bergonie.org
authors.forename: Marc
authors.initials: M
authors.lastname: Debled
authors.forename: Nicolas
authors.initials: N
authors.lastname: Madranges
authors.forename: Cécile
authors.initials: C
authors.lastname: Mertens
authors.forename: Michel
authors.initials: M
authors.lastname: Durand
authors.forename: Véronique
authors.initials: V
authors.lastname: Brouste
authors.forename: Etienne
authors.initials: E
authors.lastname: Brain
authors.forename: Louis
authors.initials: L
authors.lastname: Mauriac
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone